Dalundong, Adam Faiq M.
HRN: 24-79-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/30/2024
06/05/2024
IVT
1.2g
Q6
Pneumonia; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes